| Benefits of the Sonablate 500 |
The Sonablate 500 is a minimally invasive medical device developed by Focus Surgery, Inc. that uses HIFU to treat localized prostate cancer and benign prostatic hyperplasia (BPH) in countries where it is approved. The Sonablate 500 obtains real-time ultrasound images of the prostate and surrounding areas. From these images, the doctor plans where the ultrasound energy will be delivered. The Sonablate software allows the physician to precisely define the treatment zones in order to destroy the entire gland. Sonablate HIFU is non surgical, radiation-free and usually performed as an out-patient procedure. The Sonablate 500 is the only HIFU device for prostate cancer that does not require a transurethral resection of the prostate—known as TURP, an invasive, surgical procedure—prior to treatment in order to achieve effective results when the prostate is enlarged. The Sonablate 500 system is composed of a console, premium display monitor, transrectal ultrasound probe and the Sonachill, an active cooling system. With the addition of Tissue Change Monitoring (TCM) software, the Sonablate can detect real-time changes in the tissue during HIFU therapy guiding the user to optimal delivery of energy and enabling the assessment of indiviudal lesions. |
